A clinician's guide to ADHD treatment options

Attention deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition of children and adolescents that often persists into adulthood. Primary care physicians are commonly the first to diagnosis ADHD and initiate a treatment plan with the patient. Guidelines recommend psychostim...

Full description

Saved in:
Bibliographic Details
Published inPostgraduate medicine Vol. 129; no. 7; p. 657
Main Authors Mattingly, Gregory W, Wilson, Joshua, Rostain, Anthony L
Format Journal Article
LanguageEnglish
Published England 03.10.2017
Subjects
Adolescent
Amphetamines - therapeutic use
Attention Deficit Disorder with Hyperactivity - diagnosis
Attention Deficit Disorder with Hyperactivity - drug therapy
Central Nervous System Stimulants - therapeutic use
Child
Female
Humans
Male
Methylphenidate - therapeutic use
Practice Guidelines as Topic
amphetamine
ADHD
methylphenidate
drug delivery
psychiatry
psychostimulant
Online AccessGet more information

Cover

More Information
Summary:Attention deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition of children and adolescents that often persists into adulthood. Primary care physicians are commonly the first to diagnosis ADHD and initiate a treatment plan with the patient. Guidelines recommend psychostimulant treatment as a first-line therapy in the management plan because it has a substantial impact on alleviating the core symptoms of ADHD. The recent development of a variety of methylphenidate and amphetamine formulations provides many options to meet individual patient lifestyle needs. Liquid, chewable, sprinkled capsule, wearable patch, and orally disintegrating tablet formulations are currently available for patients who may be noncompliant with or have difficulty swallowing traditional pills. This review provides a resource for physicians to identify the stimulant delivery formulation that best suits the patient. Formulations in development are also discussed.
ISSN:1941-9260
DOI:10.1080/00325481.2017.1354648